Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)

NCT00599755 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma
Non-small Cell Lung Cancer

Interventions

RADIATION: Comparator: CT or MRI and FDG-PET
DRUG: Gemcitabine and Cisplatin or Gemcitabine and Carboplatin

Sponsor

Merck Sharp & Dohme LLC